Clinical Trial

PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study

Study acronym: PILOT PERCC
Recruiting
View on ClinicalTrials.gov →
Summary
This study is designed to evaluate whether a precision exercise regimen is feasible to implement within cancer populations, specifically stage II-III primary lung cancer patients receiving multimodal therapy, and delivered through telehealth.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-04-18; most recent amendment 2026-01-30.
Status change: Not Yet Recruiting → Recruiting 2026-01-30
Trial Details
NCT Number NCT06945484
Lead Sponsor University of Utah
Conditions NSCLC Stage II, NSCLC, Stage III
Enrollment 20 participants
Start Date 2025-11-21
Primary Completion 2027-01 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-03